{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20250520",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "50737",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208452Orig1s000TAltr.pdf",
              "date": "20171218",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA208452",
      "sponsor_name": "MYLAN",
      "openfda": {
        "application_number": [
          "ANDA208452"
        ],
        "brand_name": [
          "EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE"
        ],
        "generic_name": [
          "EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE"
        ],
        "manufacturer_name": [
          "Mylan Pharmaceuticals Inc."
        ],
        "product_ndc": [
          "0378-5440"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "EMTRICITABINE",
          "RILPIVIRINE HYDROCHLORIDE",
          "TENOFOVIR DISOPROXIL FUMARATE"
        ],
        "rxcui": [
          "1147334"
        ],
        "spl_id": [
          "d9a4185e-43fa-4aeb-9b0f-8db01b166038"
        ],
        "spl_set_id": [
          "d9a4185e-43fa-4aeb-9b0f-8db01b166038"
        ],
        "package_ndc": [
          "0378-5440-93",
          "0378-5440-77"
        ],
        "nui": [
          "N0000175462",
          "M0015066",
          "N0000009947"
        ],
        "pharm_class_epc": [
          "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_cs": [
          "Nucleosides [CS]"
        ],
        "pharm_class_moa": [
          "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
        ],
        "unii": [
          "G70B4ETF4S",
          "212WAX8KDD",
          "OTT9J7900I"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE",
          "active_ingredients": [
            {
              "name": "EMTRICITABINE",
              "strength": "200MG"
            },
            {
              "name": "RILPIVIRINE HYDROCHLORIDE",
              "strength": "EQ 25MG BASE"
            },
            {
              "name": "TENOFOVIR DISOPROXIL FUMARATE",
              "strength": "300MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}